Patwardhan Bhushan, Vaidya Ashok D B
Interdisciplinary School of Health Sciences, University of Pune, Pune 411 007, India.
Indian J Exp Biol. 2010 Mar;48(3):220-7.
The pharmaceutical industry is facing serious challenges as the drug discovery process is becoming extremely expensive, riskier and critically inefficient. A significant shift from single to multi targeted drugs especially for polygenic syndromes is being witnessed. Strategic options based on natural product drug discovery, ethnopharmacology and traditional medicines are re-emerging to offer good base as an attractive discovery engine. Approaches based on reverse pharmacology may offer efficient development platforms for herbal formulations. Relevant case studies from India and other countries where such approaches have expedited the drug discovery and development process by reducing time and economizing investments with better safety are discussed.
制药行业正面临严峻挑战,因为药物研发过程变得极其昂贵、风险更高且效率极低。我们目睹了从单一靶点药物到多靶点药物的重大转变,尤其是针对多基因综合征的药物。基于天然产物药物发现、民族药理学和传统药物的战略选择正在重新兴起,为成为有吸引力的发现引擎提供了良好基础。基于反向药理学的方法可能为草药制剂提供高效的开发平台。本文讨论了来自印度和其他国家的相关案例研究,在这些案例中,此类方法通过缩短时间、节约投资并提高安全性,加快了药物发现和开发过程。